Detectable prostate‐specific antigen after radiotherapy for clinically localized prostate cancer
Most patients undergoing RT+ADT reached a PSA ≤0.1 ng/mL within 6 and 12 months. PSA>0.1 ng/mL at these time points indicated a higher risk of PCSM, emphasizing the need for timely restaging and intensified salvage treatments.
Authors
- Peter N. Wiklund (ORCID: https://orcid.org/0000-0001-6497-4697)
- Ugo Giovanni Falagario (ORCID: https://orcid.org/0000-0002-1152-3005)
- Henrik Grönberg (ORCID: https://orcid.org/0000-0002-1073-2753)
- Giorgio Gandaglia (ORCID: https://orcid.org/0000-0002-5052-721X)
- Tobias Nordström (ORCID: https://orcid.org/0000-0003-4915-7546)
- Alexander Valdman (ORCID: https://orcid.org/0000-0001-7281-0991)
- Alberto Briganti (ORCID: https://orcid.org/0000-0002-2178-0494)
- Marie Hjelm Eriksson
- Anna Lantz (ORCID: https://orcid.org/0000-0002-5335-8028)
- Francesco Pellegrino (ORCID: https://orcid.org/0000-0002-7828-6876)
- Renata Zelić (ORCID: https://orcid.org/0000-0002-8842-5964)
- Olof Akre (ORCID: https://orcid.org/0000-0002-3750-3029)
- Lars Björnebo (ORCID: https://orcid.org/0000-0002-5573-0794)
- Francesco Montorsi (ORCID: https://orcid.org/0000-0002-7267-4181)
- Thorgerdur Palsdottir (ORCID: https://orcid.org/0000-0003-3491-3986)
- Martin Eklund (ORCID: https://orcid.org/0000-0001-5032-5266)
- Ahmad Abbadi (ORCID: https://orcid.org/0000-0001-9373-668X)
- Markus Aly
- Giuseppe Carrieri
Institutions
- University of Foggia (IT)
- Vita-Salute San Raffaele University (IT)
- Karolinska Institutet (SE)
- Saint Göran Hospital (SE)
- St Göran's Children's Hospital (SE)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Cancer
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1002/cncr.70045
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Association of Urology